Page 3 - Best Liver cancer stage 2 doctors: TOP 82 doctors

Chief Physician at a certified interdisciplinary cancer center, Phd Viola Fox specializes in innovative treatments for liver cancer. Her research in molecular biology has advanced cancer therapies.

• Specialized in chemotherapy, immunotherapy, and targeted therapies
• Qualified specialist in genetics with a focus on oncology
• Active member of the American Association for Cancer Research

Professor Keil specializes in diagnostic and interventional radiology, with a focus on liver cancer imaging and interventions at the Academic Hospital Solingen.

• Graduated with honors from Julius-Maximilians-Universität Würzburg
• Trained under renowned Professor Rolf W. Günther in Aachen
• Expert in modern imaging techniques like MRI, CT, and ultrasound
• Chief Physician at the Clinic for Diagnostic and Interventional Radiology since 2022

Assoc. Prof. Nail Paksoy is an ESMO-certified medical oncologist at Medipol Bahçelievler Hospital, specializing in liver cancer with extensive clinical trial experience.

• Completed fellowship at Istanbul University Oncology Institute
• Subinvestigator in 8 international oncology clinical trials
• Published multiple studies on cancer treatment efficacy
• Specializes in personalized treatment approaches

Dr. Auala Hubert leads the Gastrointestinal Cancer Center at Hadassah Medical Center, bringing 36 years of experience of focused oncology expertise.

• Specializes in Medical Oncology & Radiotherapy
• Head of Gastrointestinal Cancer Center at Hadassah
• Board-certified in Oncology & Radiotherapy
• Member of Israel Society of Clinical Oncology
• Fluent in English and Hebrew for international patients

Specialized in laparoscopic and oncological cancer surgery with training at Istanbul University. Dr. Al focuses on minimally invasive techniques for liver cancer.

• Trained in advanced laparoscopic surgery at Cerrahpaşa Faculty of Medicine
• Performs laparoscopic bariatric and anti-reflux surgeries
• Graduated from Ondokuz Mayıs University Faculty of Medicine
• Specialized at KTÜ Faculty of Medicine Farabi Hospital

Associate Professor Babek Tabandeh is an expert surgeon specializing in liver cancer and minimally invasive techniques. He performs complex liver surgeries at Medical Park Göztepe Hospital.

• Over of experience in general and cancer surgery
• Focuses on minimally invasive surgery for better recovery
• Published author with 40+ scientific papers
• Member of the prestigious American College of Surgeons
• Also holds membership in the Liver Transplantation Society

Dr. Ozden brings over 27 years of experience of expertise in oncology, honed through diverse clinical roles across Turkey.

• Specialized in medical oncology with a focus on liver cancer
• Trained at Istanbul University's renowned Cerrahpaşa Faculty of Medicine
• Extensive experience in both private and university hospital settings
• Committed to personalized treatment plans for each patient

Specializing in virotherapy – one of the newest immunology fields – Dr. Jaunalksne brings 49 years of experience of experience to liver cancer treatment.

• Head of Clinical Immunology Center at Pauls Stradins Clinical University Hospital
• Graduate of Riga Medical Institute with internship in Internal Medicine
• Focuses on cutting-edge immunological approaches to cancer

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Liuying leads the Oncology Ward at Jinshazhou Hospital, Guangzhou University of Chinese Medicine. Clinical focus includes hepatocellular carcinoma, cholangiocarcinoma, and lung and colorectal cancers. Dr. Liuying has special expertise in melanoma and melanoma liver metastasis. Interventional skills include MWA, RFA, cryoablation, and radioactive seed implantation for non-vascular, minimally invasive tumor ablation.

Research: participated in two Guangdong Provincial science and technology projects. Contributed to the 2014 Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors. Published in the Chinese Journal of Lung Cancer. Compiled Selected Cases of Microwave Ablation for Lung Tumors and Selected Cases of Microwave Ablation for Liver Tumors.

Appointments: Standing Committee Member, Youth Committee of Intra-Tumor Brachytherapy Medicine, China Medical Education Association. Standing Committee Member, Minimally Invasive Interventional Medicine Professional Committee, Guangdong Primary Medical Association.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Zalmanova specializes in radiotherapy at Assuta Medical Center, focusing on liver cancer treatments.

• Radiotherapist with expertise in liver cancer stage 2
• Works at Assuta Medical Center, a leading healthcare facility
• Dedicated to personalized treatment plans for each patient

Dr. Alexander Beny is a Board Certified Oncologist with extensive training in medical and radiation oncology, specializing in liver cancer at Rambam Medical Center.

• Head of Gastrointestinal Malignant Service at Rambam Medical Center
• Trained in Italy and Israel with European board certification
• Specializes in both medical and radiation oncology approaches
• Leads dedicated gastrointestinal and onco-gynecology clinics

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.